Merit Financial Group »

Sarepta Therapeutics shares owned by Merit Financial Group

Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by Merit Financial Group from 13F filings

Historical chart of Merit Financial Group investment in Sarepta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics held by Merit Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics by Merit Financial Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $626k 29k 21.76
2025-12-31 $820k 38k 21.52

More positions owned by Merit Financial Group

Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Core S&p Us Gwt (IUSG)
Gmo Etf Trust Gmo Us Quality E (QLTY)
Ishares Tr Core S&p Us Vlu (IUSV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Vanguard World Mega Grwth Ind (MGK)
Vanguard Index Fds Value Etf (VTV)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Vanguard World Mega Cap Val Etf (MGV)
Spdr Series Trust State Street Spd (SPTI)
Ishares Tr Eafe Value Etf (EFV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Blackrock Etf Trust Ishares Intl Ctr (CORO)

View all positions for Merit Financial Group

Top funds holding Sarepta Therapeutics

BlackRock
Vanguard Group
Vanguard Portfolio Management
State Street Corporation
AQR Capital Management
Two Sigma Investments
Vanguard Capital Management
First Trust Advisors
RA Capital Management
Susquehanna International
Erste Asset Management GmbH
Morgan Stanley
Standard Life Aberdeen
Citadel Advisors
UBS Group

View all funds holding Sarepta Therapeutics